Kardium Raises $250M as Its Pulsed Field Ablation System Undergoes FDA Review

B.C. medtech Kardium lands US$250M to bring heart-rhythm device to market

British Columbia medical technology company Kardium to expand manufacturing and pursue regulatory approvals for its atrial fibrillation technology

Kardium raises $250M as its pulsed field ablation system undergoes FDA review

The pulsed field ablation developer collected $250 million to gear up for the commercial launch of its Globe system, planned for later this year.

Kardium Announces $250M (CA$340M) Financing to Launch Innovative Atrial Fibrillation Treatment

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jul 2, 2025-

Kardium raises $340-million as B.C. heart device maker prepares for FDA approval, market entry

Company’s device treats atrial fibrillation, a heartbeat disorder that affects more than 59 million people worldwide

Kardium raises $250m to support PFA system launch

Kardium has raised C$340m ($250m) to support the launch of its Globe pulsed field (PF) System for treating atrial fibrillation (AFib).The post Kardium raises $250m to support PFA system launch appeared first on Medical Device Network.

Kardium Captures US$250M in Capital for the Commercial Launch of 'Globe System' Solution

Kardium has raised a sizeable round of financing, the Vancouver-based medical solutions company announced this week. The Canadian innovator confirmed US$250 million in an oversubscribed round led by investors Janus Henderson Investors, Qatar Investment Authority , MMCAP, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital. Existing investors also participated. “We’re thrilled to have secured this transformational f…